Prevalence of celiac disease in risk group patients in nizhny novgorod region


Cite item

Full Text

Abstract

Aim. To estimate prevalence of gluten celiac disease (GCD) in Nizhny Novgorod region by the data of examination of patients from high risk group. Material and methods. Outpatient examination was made in 41245 outpatients. GCD risk groups included patients with chronic diarrhea and other manifestations of enteropathy, iron deficiency anemia of unclear genesis, with autoimmune disorders, skin diseases associated with GD, women with reproductive dysfunction of unclear genesis, persons with low body mass, close relatives of GCD patients. All the patients were examined conventionally. Antiglutenic antibodies (AGA) and/or antibodies to tissue transglutaminase (AB TTG) in IgA and IgG were determined and morphological tests of duodenal mucosa were made in patients at high risk of GC. Results. Out of 41245 examinees 2364 (5.7%) were expected to have CD. Immunological tests were performed in 1045 risk group patients. Of them, 251 patients had elevated titers of AGA and/or AB TTG. Histological examination discovered GCD signs in 210 patients with positive AGA and/or AB TTG and in 101 patients who were not examined immunologically. GCD was detected in 311 (13.1%) patients included in risk groups. Conclusion. Prevalence of CD in adults with risk factors is 1:7.6, in outpatients - 1:133. For active GCD screening in risk groups blood tests for AGA and AB TTG should be made. Those with a high titer of these antibodies and patients with chronic diarrhea and malabsorption should undergo biopsy material taken from the duodenum in esophagogastroduodenoscopy.

About the authors

A A Repin

Нижегородский областной клинический диагностический центр

Iu A Bogdarin

Нижегородский научно-исследовательский институт детской гастроэнтерологии Росздрава

B V Sarantsev

Нижегородский областной клинический диагностический центр

O V Teplov

Нижегородский областной клинический диагностический центр

N V Desiatnikova

Нижегородский областной клинический диагностический центр

A I Parfenov

ЦНИИ гастроэнтерологии, Москва

References

  1. Парфенов А. И. Целиакия. Эволюция представлений о распространенности, клинических проявлений и значимости этиотропной терапии. М.: Анахарсис; 2007. 50-54.
  2. Cook Н. В., Burt М. J., Collett J. A. et al. Adult coeliac disease: prevalence and clinical significance. J. Gastroenterol. Hepatol. 2000; 15 (9): 1032-1036.
  3. Gomez J. C., Selvaggio G. S., Viola M. et al. Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area. Am. J. Gastroenterol. 2001; 96 (9): 2700-2704.
  4. Fasano A., Berti I., Gerarduzzi T. et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States; a large multicenter study. Arch. Intern. Med. 2003; 163: 286-292.
  5. Duby C., Rostom A., Sy R. et al. The prevalence of celiac disease in average-risk and at-risk Western European: A systematic review. Gastroenterology 2005; 128 (4, suppl. 1).
  6. McManus R., Kelleher D. Celiac disease - the villain unmasked? N. Engl. J. Med. 2003; 348: 2573-2574.
  7. Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 2005; 128 (4, pt 2): S68-S73.
  8. Парфенов А. И., Жукова С. Г., Гудкова Р. Б. и др. Диагностика и оценка эффективности лечения глютеновой энтеропатии. Тер. арх. 2002; 2: 27-31.
  9. Maki М. Tissue transglutaminase as the autoantigen of coeliac disease. Gut 1997; 41: 565-566.
  10. Gillett H. R., Cauch-Dudek K., Jenny E. et al. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can. J. Gastroenterol. 200; 14: 665-666.
  11. McMillan S. A., Haughton D. J., Biggart J. D. et al. Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. Br. Med. J. 1991; 303 (6811): 1163-1165.
  12. Marsh M. N. Mucosal pathology in gluten sensitivity. In: Marsh M. N. ed. Coeliac disease. Oxford: Blackwell Scientific; 1992. 136-191.
  13. Парфенов А. И., Крумс Л. M., Сабельникова Е. А. Современная концепция, дефиниция и классификация целиакии. В кн.: Материалы V Съезда Научного о-ва гастроэнтерологов России. М.: Анахарсис; 2005. 473-475.
  14. Mustalahti К., Reananen A., Heuer M. et al. Prevalence of соеliас disease in four European countries. In: The 11th International symposium “Coeliac disease". Belfast, Northern Ireland; 2004. P60
  15. Парфенов А. И., Сабельникова E. А., Крумс Л. М., Гудкова P. Б. Частота целиакии у больных с хронической диареей. Тер. арх. 2003; 9: 55-60.
  16. Сабельникова Е. А., Парфенов А. И., Крумс Л. М., Губкова Р. Б. Целиакия как причина железодефицитной анемии. Тер. арх. 2006; 2: 45-48.
  17. Sanders D. S., Hurlstone D. P., Stokes R. O. et al. Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshine. Postgrad. Med. J. 2002; 78: 31-33.
  18. James W. J., Scott В. B. Coeliac disease: the cause of the various associated disorders? Gastroenterol. Hepatol. 2001; 13: 1119-1121.
  19. Schupan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234-242.

Copyright (c) 2008 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies